Relypsa Inc (NASDAQ:RLYP)

Data as of Nov 21
 +0.78 / +3.40%
Today’s Change
Today|||52-Week Range
Health Technology
Pharmaceuticals: Other

Company Description

Relypsa, Inc. operates as a clinical-stage pharmaceutical company focused on the development and commercialization of non absorbed polymeric drugs to treat disorders in the areas of renal, cardiovascular and metabolic diseases. Its products include patiromer, a non-absorbed potassium binder for the treatment of hyperkalemia and RLY6002, polymer drug discovery technology. The company was founded on October 29, 2007 and is headquartered in Redwood City, CA.

Contact Information

Relypsa, Inc.
700 Saginaw Drive
Redwood City California 94063
P:(650) 421-9500
Investor Relations:



Other institutional47.75%
Individual stakeholders45.03%
Mutual fund holders21.51%

Top Executives

John A. OrwinPresident, Chief Executive Officer & Director
Wilhelm StahlSenior Vice President-Pharmaceutical Operations
Kristine McClintock BallChief Financial Officer & Senior Vice President
Jerry M. BuysseChief Scientific Officer & Senior VP-Research
Lance BermanChief Medical Officer & Senior Vice President

To view my watchlist

Not a member yet?

Sign up now for a free account

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2014 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2014. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2014 and/or its affiliates.